Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene.

Honig MG, Del Mar NA, Henderson DL, Ragsdale TD, Doty JB, Driver JH, Li C, Fortugno AP, Mitchell WM, Perry AM, Moore BM, Reiner A.

Exp Neurol. 2019 Dec;322:113063. doi: 10.1016/j.expneurol.2019.113063. Epub 2019 Sep 10.

2.

Rugby Player's Aorta: Alarming Prevalence of Ascending Aortic Dilatation and Effacement in Elite Rugby Players.

Kay S, Moore BM, Moore L, Seco M, Barnes C, Marshman D, Grieve SM, Celermajer DS.

Heart Lung Circ. 2019 Jun 28. pii: S1443-9506(19)31323-X. doi: 10.1016/j.hlc.2019.06.714. [Epub ahead of print]

PMID:
31494040
3.

Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.

Guley NM, Del Mar NA, Ragsdale T, Li C, Perry AM, Moore BM, Honig MG, Reiner A.

Exp Eye Res. 2019 May;182:109-124. doi: 10.1016/j.exer.2019.03.013. Epub 2019 Mar 26.

4.

Catheter Ablation for Atrial Fibrillation in Heart Failure: Ready for Mainstream Adoption, or Is More Evidence Needed?

Moore BM, Chan KH, Sy RW.

Heart Lung Circ. 2019 May;28(5):665-666. doi: 10.1016/j.hlc.2019.02.006. Epub 2019 Feb 25. No abstract available.

PMID:
30846417
5.

Activation of the cannabinoid receptor 2 increases renal perfusion.

Pressly JD, Soni H, Jiang S, Wei J, Liu R, Moore BM, Adebiyi A, Park F.

Physiol Genomics. 2019 Mar 1;51(3):90-96. doi: 10.1152/physiolgenomics.00001.2019. Epub 2019 Feb 1.

PMID:
30707046
6.

Robust predictions of specialized metabolism genes through machine learning.

Moore BM, Wang P, Fan P, Leong B, Schenck CA, Lloyd JP, Lehti-Shiu MD, Last RL, Pichersky E, Shiu SH.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2344-2353. doi: 10.1073/pnas.1817074116. Epub 2019 Jan 23. Erratum in: Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5830.

7.

Cryoballoon Versus Radiofrequency Ablation for Atrial Fibrillation - Is There a Role for Individualised Patient Selection?

Moore BM, Sy RW.

Heart Lung Circ. 2019 Apr;28(4):511-518. doi: 10.1016/j.hlc.2018.11.012. Epub 2018 Dec 3. No abstract available.

PMID:
30528213
8.

Ablation of Atrial Arrhythmias After the Atriopulmonary Fontan Procedure: Mechanisms of Arrhythmia and Outcomes.

Moore BM, Anderson R, Nisbet AM, Kalla M, du Plessis K, d'Udekem Y, Bullock A, Cordina RL, Grigg L, Celermajer DS, Kalman J, McGuire MA.

JACC Clin Electrophysiol. 2018 Oct;4(10):1338-1346. doi: 10.1016/j.jacep.2018.08.012.

PMID:
30336880
9.

A wobbling tachycardia: What is the mechanism?

Moore BM, Sy RW, Chan KH.

Heart Rhythm. 2018 Oct;15(10):1583-1584. doi: 10.1016/j.hrthm.2018.06.015. No abstract available.

PMID:
30274619
10.

Factors Influencing Gene Family Size Variation Among Related Species in a Plant Family, Solanaceae.

Wang P, Moore BM, Panchy NL, Meng F, Lehti-Shiu MD, Shiu SH.

Genome Biol Evol. 2018 Oct 1;10(10):2596-2613. doi: 10.1093/gbe/evy193.

11.

Adverse effects of amiodarone therapy in adults with congenital heart disease.

Moore BM, Cordina RL, McGuire MA, Celermajer DS.

Congenit Heart Dis. 2018 Nov;13(6):944-951. doi: 10.1111/chd.12657. Epub 2018 Sep 21.

PMID:
30239160
12.

An Examination of the Moderating Effect of Proactive Coping in NICU Nurses.

Moore BM, Schellinger K.

J Perinat Neonatal Nurs. 2018 Jul/Sep;32(3):275-285. doi: 10.1097/JPN.0000000000000353.

PMID:
30036310
13.

The Effect of Active Physical Training Interventions on Reactive Postural Responses in Older Adults: A Systematic Review.

Moore BM, Adams JT, Willcox S, Nicholson J.

J Aging Phys Act. 2019 Apr 1;27(2):252-264. doi: 10.1123/japa.2017-0347. Epub 2018 Nov 13.

PMID:
29989462
14.

Efficacy and adverse effects of sotalol in adults with congenital heart disease.

Moore BM, Cordina RL, McGuire MA, Celermajer DS.

Int J Cardiol. 2019 Jan 1;274:74-79. doi: 10.1016/j.ijcard.2018.06.066. Epub 2018 Jun 20.

PMID:
29954667
15.

Causes of death in a contemporary adult congenital heart disease cohort.

Yu C, Moore BM, Kotchetkova I, Cordina RL, Celermajer DS.

Heart. 2018 Oct;104(20):1678-1682. doi: 10.1136/heartjnl-2017-312777. Epub 2018 Apr 17.

PMID:
29666178
16.

Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts.

Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, Moore BM 2nd.

Arch Oral Biol. 2018 Mar;87:79-85. doi: 10.1016/j.archoralbio.2017.12.005. Epub 2017 Dec 6.

PMID:
29274621
17.

Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.

Pressly JD, Mustafa SM, Adibi AH, Alghamdi S, Pandey P, Roy KK, Doerksen RJ, Moore BM Jr, Park F.

J Pharmacol Exp Ther. 2018 Feb;364(2):287-299. doi: 10.1124/jpet.117.245522. Epub 2017 Nov 29.

18.

Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189.

Liu Y, McAfee SS, Guley NM, Del Mar N, Bu W, Heldt SA, Honig MG, Moore BM 2nd, Reiner A, Heck DH.

eNeuro. 2017 Aug 18;4(4). pii: ENEURO.0387-16.2017. doi: 10.1523/ENEURO.0387-16.2017. eCollection 2017 Jul-Aug.

19.

Transcatheter Mitral Valve Replacement With a Novel Dual Stent Bioprosthesis.

Moore BM, Ng HKB, Naoum C, Simmons L, Cartwright BL, Wilson MK, Ng MKC.

Circ Cardiovasc Interv. 2017 Jun;10(6). pii: e004841. doi: 10.1161/CIRCINTERVENTIONS.116.004841. No abstract available.

PMID:
28566291
20.
21.

Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620.

Cochran BJ, Hou L, Manavalan AP, Moore BM, Tabet F, Sultana A, Cuesta Torres L, Tang S, Shrestha S, Senanayake P, Patel M, Ryder WJ, Bongers A, Maraninchi M, Wasinger VC, Westerterp M, Tall AR, Barter PJ, Rye KA.

Diabetes. 2017 Feb;66(2):560. doi: 10.2337/db17-er02b. Epub 2016 Dec 1. No abstract available.

22.

Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist.

Bu W, Ren H, Deng Y, Del Mar N, Guley NM, Moore BM, Honig MG, Reiner A.

Front Neurosci. 2016 Oct 6;10:449. eCollection 2016.

23.

Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism.

Cochran BJ, Hou L, Manavalan AP, Moore BM, Tabet F, Sultana A, Cuesta Torres L, Tang S, Shrestha S, Senanayake P, Patel M, Ryder WJ, Bongers A, Maraninchi M, Wasinger VC, Westerterp M, Tall AR, Barter PJ, Rye KA.

Diabetes. 2016 Dec;65(12):3610-3620. Epub 2016 Oct 4. Erratum in: Diabetes. 2017 Feb;66(2):560.

24.

Optimization of cAMP fluorescence dataset from ACTOne cannabinoid receptor 1 cell line.

Presley CS, Abidi AH, Moore BM 2nd.

Data Brief. 2016 Apr 1;7:1118-23. doi: 10.1016/j.dib.2016.03.086. eCollection 2016 Jun.

25.

Corrigendum to 'Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system' [Analytical Biochemistry 498 (2016) 8-28].

Presley CS, Abidi AH, Moore BM 2nd.

Anal Biochem. 2016 May 15;501:47. doi: 10.1016/j.ab.2016.03.002. Epub 2016 Mar 15. No abstract available.

PMID:
27064120
26.

An Exploratory Examination of College Students' Likelihood of Reporting Sexual Assault to Police and University Officials: Results of a Self-Report Survey.

Moore BM, Baker T.

J Interpers Violence. 2018 Nov;33(22):3419-3438. doi: 10.1177/0886260516632357. Epub 2016 Feb 24.

PMID:
26917571
27.

Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.

Presley CS, Abidi AH, Moore BM 2nd.

Anal Biochem. 2016 Apr 1;498:8-28. doi: 10.1016/j.ab.2015.12.019. Epub 2016 Jan 7. Erratum in: Anal Biochem. 2016 May 15;501:47.

PMID:
26772161
28.

Efficient transgenesis mediated by pigmentation rescue in zebrafish.

Harrold I, Carbonneau S, Moore BM, Nguyen G, Anderson NM, Saini AS, Kanki JP, Jette CA, Feng H.

Biotechniques. 2016 Jan 1;60(1):13-20. doi: 10.2144/000114368. eCollection 2016 Jan.

29.

Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.

Presley CS, Mustafa SM, Abidi AH, Moore BM 2nd.

Bioorg Med Chem. 2015 Sep 1;23(17):5390-401. doi: 10.1016/j.bmc.2015.07.057. Epub 2015 Jul 29.

PMID:
26275680
30.

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.

Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm B, Moore BM.

Pharmacol Res Perspect. 2015 Aug;3(4):e00159. doi: 10.1002/prp2.159. Epub 2015 Jul 6.

31.

How to Appropriately Calculate Effective Dose for CT Using Either Size-Specific Dose Estimates or Dose-Length Product.

Brady SL, Mirro AE, Moore BM, Kaufman RA.

AJR Am J Roentgenol. 2015 May;204(5):953-8. doi: 10.2214/AJR.14.13317. Epub 2015 Mar 2.

PMID:
25729893
32.

Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189.

Reiner A, Heldt SA, Presley CS, Guley NH, Elberger AJ, Deng Y, D'Surney L, Rogers JT, Ferrell J, Bu W, Del Mar N, Honig MG, Gurley SN, Moore BM 2nd.

Int J Mol Sci. 2014 Dec 31;16(1):758-87. doi: 10.3390/ijms16010758.

33.

The Kv1.1 null mouse, a model of sudden unexpected death in epilepsy (SUDEP).

Moore BM, Jerry Jou C, Tatalovic M, Kaufman ES, Kline DD, Kunze DL.

Epilepsia. 2014 Nov;55(11):1808-16. doi: 10.1111/epi.12793. Epub 2014 Nov 6.

34.

Size-specific dose estimate (SSDE) provides a simple method to calculate organ dose for pediatric CT examinations.

Moore BM, Brady SL, Mirro AE, Kaufman RA.

Med Phys. 2014 Jul;41(7):071917. doi: 10.1118/1.4884227.

35.

An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge.

Brownstein CA, Beggs AH, Homer N, Merriman B, Yu TW, Flannery KC, DeChene ET, Towne MC, Savage SK, Price EN, Holm IA, Luquette LJ, Lyon E, Majzoub J, Neupert P, McCallie D Jr, Szolovits P, Willard HF, Mendelsohn NJ, Temme R, Finkel RS, Yum SW, Medne L, Sunyaev SR, Adzhubey I, Cassa CA, de Bakker PI, Duzkale H, Dworzyński P, Fairbrother W, Francioli L, Funke BH, Giovanni MA, Handsaker RE, Lage K, Lebo MS, Lek M, Leshchiner I, MacArthur DG, McLaughlin HM, Murray MF, Pers TH, Polak PP, Raychaudhuri S, Rehm HL, Soemedi R, Stitziel NO, Vestecka S, Supper J, Gugenmus C, Klocke B, Hahn A, Schubach M, Menzel M, Biskup S, Freisinger P, Deng M, Braun M, Perner S, Smith RJ, Andorf JL, Huang J, Ryckman K, Sheffield VC, Stone EM, Bair T, Black-Ziegelbein EA, Braun TA, Darbro B, DeLuca AP, Kolbe DL, Scheetz TE, Shearer AE, Sompallae R, Wang K, Bassuk AG, Edens E, Mathews K, Moore SA, Shchelochkov OA, Trapane P, Bossler A, Campbell CA, Heusel JW, Kwitek A, Maga T, Panzer K, Wassink T, Van Daele D, Azaiez H, Booth K, Meyer N, Segal MM, Williams MS, Tromp G, White P, Corsmeier D, Fitzgerald-Butt S, Herman G, Lamb-Thrush D, McBride KL, Newsom D, Pierson CR, Rakowsky AT, Maver A, Lovrečić L, Palandačić A, Peterlin B, Torkamani A, Wedell A, Huss M, Alexeyenko A, Lindvall JM, Magnusson M, Nilsson D, Stranneheim H, Taylan F, Gilissen C, Hoischen A, van Bon B, Yntema H, Nelen M, Zhang W, Sager J, Zhang L, Blair K, Kural D, Cariaso M, Lennon GG, Javed A, Agrawal S, Ng PC, Sandhu KS, Krishna S, Veeramachaneni V, Isakov O, Halperin E, Friedman E, Shomron N, Glusman G, Roach JC, Caballero J, Cox HC, Mauldin D, Ament SA, Rowen L, Richards DR, San Lucas FA, Gonzalez-Garay ML, Caskey CT, Bai Y, Huang Y, Fang F, Zhang Y, Wang Z, Barrera J, Garcia-Lobo JM, González-Lamuño D, Llorca J, Rodriguez MC, Varela I, Reese MG, De La Vega FM, Kiruluta E, Cargill M, Hart RK, Sorenson JM, Lyon GJ, Stevenson DA, Bray BE, Moore BM, Eilbeck K, Yandell M, Zhao H, Hou L, Chen X, Yan X, Chen M, Li C, Yang C, Gunel M, Li P, Kong Y, Alexander AC, Albertyn ZI, Boycott KM, Bulman DE, Gordon PM, Innes AM, Knoppers BM, Majewski J, Marshall CR, Parboosingh JS, Sawyer SL, Samuels ME, Schwartzentruber J, Kohane IS, Margulies DM.

Genome Biol. 2014 Mar 25;15(3):R53. doi: 10.1186/gb-2014-15-3-r53.

36.

Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity.

Brocato B, Zoerner AA, Janjetovic Z, Skobowiat C, Gupta S, Moore BM 2nd, Slominski A, Zhang J, Schenone M, Phinehas R, Ferry RJ Jr, Dick E Jr, Hubbard GB, Mari G, Schlabritz-Loutsevitch N.

Placenta. 2013 Nov;34(11):983-9. doi: 10.1016/j.placenta.2013.08.007. Epub 2013 Sep 2.

37.

Pediatric CT: implementation of ASIR for substantial radiation dose reduction while maintaining pre-ASIR image noise.

Brady SL, Moore BM, Yee BS, Kaufman RA.

Radiology. 2014 Jan;270(1):223-31. doi: 10.1148/radiol.13122578. Epub 2013 Oct 28.

38.

Tracheostomy for infants requiring prolonged mechanical ventilation: 10 years' experience.

Overman AE, Liu M, Kurachek SC, Shreve MR, Maynard RC, Mammel MC, Moore BM.

Pediatrics. 2013 May;131(5):e1491-6. doi: 10.1542/peds.2012-1943. Epub 2013 Apr 8.

PMID:
23569088
39.

Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1.

Moore BM, Laguna TA, Liu M, McNamara JJ.

Pediatr Pulmonol. 2013 Aug;48(8):747-53. doi: 10.1002/ppul.22665. Epub 2012 Sep 19.

40.

Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.

Gurley SN, Abidi AH, Allison P, Guan P, Duntsch C, Robertson JH, Kosanke SD, Keir ST, Bigner DD, Elberger AJ, Moore BM 2nd.

J Neurooncol. 2012 Nov;110(2):163-77. doi: 10.1007/s11060-012-0958-5. Epub 2012 Aug 9.

PMID:
22875710
41.

Utilization of health care services by pregnant mothers during delivery: a community based study in Nigeria.

Moore BM, Alex-Hart BA, George IO.

East Afr J Public Health. 2011 Mar;8(1):49-51.

PMID:
22066284
42.

The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy.

Moore BM, Savdie R, PeBenito RA, Haynes AM, Matthews J, Delprado W, Rasiah KK, Stricker PD.

BJU Int. 2012 Feb;109(4):533-8. doi: 10.1111/j.1464-410X.2011.10361.x. Epub 2011 Jun 28.

43.

Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock.

Vaddady PK, Mehrotra N, Zhang X, Yates CR, Moore BM, Meibohm B.

Biopharm Drug Dispos. 2011 Mar;32(2):89-98. doi: 10.1002/bdd.740. Epub 2010 Dec 23.

PMID:
21341278
44.

Low-volume binary drug therapy for the treatment of hypovolemia.

Bhattacharjee H, Nadipuram A, Kosanke S, Kiani MF, Moore BM 2nd.

Shock. 2011 Jun;35(6):590-6. doi: 10.1097/SHK.0b013e3182150e80.

PMID:
21330941
45.

Incidental sinusitis in a pediatric intensive care unit.

Moore BM, Blumberg K, Laguna TA, Liu M, Zielinski EE, Kurachek SC.

Pediatr Crit Care Med. 2012 Mar;13(2):e64-8. doi: 10.1097/PCC.0b013e31820ac3f5.

46.

Fluoroalkylated silicon-containing surfaces-estimation of solid-surface energy.

Chhatre SS, Guardado JO, Moore BM, Haddad TS, Mabry JM, McKinley GH, Cohen RE.

ACS Appl Mater Interfaces. 2010 Dec;2(12):3544-54. doi: 10.1021/am100729j. Epub 2010 Nov 10.

PMID:
21067201
47.

Protease sensing with nanoparticle based platforms.

Welser K, Adsley R, Moore BM, Chan WC, Aylott JW.

Analyst. 2011 Jan 7;136(1):29-41. doi: 10.1039/c0an00429d. Epub 2010 Sep 28. Review.

PMID:
20877821
48.

Epilepsy: an anticipatory presentation of pediatric Wegener's granulomatosis.

Moore BM, Rothman SM, Clark HB, Vehe RK, Laguna TA.

Pediatr Neurol. 2010 Jul;43(1):49-52. doi: 10.1016/j.pediatrneurol.2010.03.014.

PMID:
20682204
49.

Paternal behavior increases testosterone levels in offspring of the California mouse.

Becker EA, Moore BM, Auger C, Marler CA.

Horm Behav. 2010 Aug;58(3):385-9. doi: 10.1016/j.yhbeh.2010.03.019. Epub 2010 Apr 1.

PMID:
20362577
50.

Evaluation of novel vanilloid-based hemostatic agents in rats.

Bhattacharjee H, Gurley SN, Allison PB, Zhang X, Moore BM 2nd.

J Trauma. 2010 Mar;68(3):676-81. doi: 10.1097/TA.0b013e3181b0d616.

PMID:
19996803

Supplemental Content

Loading ...
Support Center